14 completed, 9 unknown, 2 active not recruiting, 2 terminated. 29 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 29 | Completed 14, Unknown 9, Active not recruiting 2, Terminated 2, Suspended 1, Withdrawn 1 |
| Phase 2 | 9 | Completed 5, Unknown 3, Terminated 1 |
Follow Carnitine: new trials by email Literature Review of Carnitine trials Research Report on Carnitine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men L-carnitine - Oligoasthenozoospermia, Male Infertility | Phase 3 | Active not recruiting | South Valley University | 50 | 2026-01-01 | 2026-02-11 |
| Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia. Letrozole 2.5mg, L-carnitine - Idiopathic Oligoasthenoteratozoospermia, Male Infertility | Phase 2 / Phase 3 | Completed | Tehran University of Medical Sciences | 90 | 2023-12-01 | 2026-06-30 |
| Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Biospecimen Collection, Calaspargase Pegol, Levocarnitine - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 3 | Active not recruiting | Children's Oncology Group | 440 | 2023-08-24 | 2026-08-21 |
| Evaluation of the Impact of L- Carnitine in Intradialytic Hypotension in Pediatric Patients on Regular Hemodialysis L Carnitine - Intradialytic Hypotension | Phase 3 | Unknown | Ain Shams University | 50 | 2023-05-30 | 2023-06-15 |
| L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis L-carnitine - Rheumatoid Arthritis | Phase 3 | Unknown | Tanta University | 46 | 2023-03-05 | 2023-03-31 |
| Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease L-Carnitine 500Mg thrice daily, 1g L-Carnitine IV three times a week - Hemodialysis Complication | Phase 2 / Phase 3 | Completed | Bahria University | 83 | 2023-01-01 | 2024-08-09 |
| The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma Placebo, L-Carnitine 500Mg Oral Tablet, Biotin Capsules - Moderate Persistent Asthma | Phase 3 | Unknown | Tanta University | 66 | 2022-08-08 | 2022-11-30 |
| Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg, Atorvastatin 10mg - Dyslipidemias, Cardiovascular Risk Factor | Phase 3 | Unknown | Laboratorios Grossman, S.A. | 120 | 2018-05-28 | 2019-02-26 |
| L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors L-carnitine, Placebo - Gastrointestinal Stromal Tumors (GISTs) | Phase 3 | Completed | Asan Medical Center | 4 | 2018-03-01 | 2020-07-13 |
| L-carnitine for Fatigue in COPD L-carnitine 1000 mg twice daily, Weekly health coaching calls, Placebo capsules - Copd, Fatigue | Phase 2 / Phase 3 | Completed | Mayo Clinic | 33 | 2017-01-01 | 2019-01-23 |
| Impact on Functional Status in Older Adults Treated With L-Carnitine L Carnitine, Supervised exercise, Placebos - Carnitine; Muscle, Functional Status | Phase 2 / Phase 3 | Unknown | Hospital de Clínicas Dr. Manuel Quintela | 60 | 2017-01-01 | 2017-06-08 |
| L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients L-carnitine, usual intake - Ammonia Metabolism | Phase 2 / Phase 3 | Unknown | Kochi University | 80 | 2016-04-01 | 2017-01-16 |
| Carnitine Supplementation and Skeletal Muscle Function carnitine, placebo - Sarcopenia | Phase 3 | Completed | Gdansk University of Physical Education and Sport | 28 | 2016-02-01 | 2019-05-23 |
| Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration Hydration strategy using saline, Hydration strategy using sodium bicarbonate, L-carnitine - Acute Kidney Injury, Renal Insufficiency | Phase 3 | Terminated | Centre Hospitalier Universitaire de Nīmes | 9 | 2014-12-01 | 2016-03-22 |
| An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne Adapalene gel with Eucerin, Adapalene gel, Adapalene gel with placebo moisturizer - Acne | Phase 3 | Completed | Mahidol University | 120 | 2014-07-01 | 2017-01-23 |
| L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis L-carnitine - Acute Pyelonephritis(APN) | Phase 3 | Unknown | Shahid Beheshti University | 78 | 2013-11-01 | 2013-12-11 |
| Valproate and Levocarnitine in Children With Spinal Muscular Atrophy Valproate, Levocarnitine, Placebo - Spinal Muscular Atrophy | Phase 3 | Unknown | All India Institute of Medical Sciences | 60 | 2013-08-01 | 2016-01-01 |
| The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome Coenzyme Q10U, L-carnitine - Myelodysplastic Syndrome | Phase 2 / Phase 3 | Unknown | Kaplan Medical Center | 40 | 2013-05-01 | 2014-01-22 |
| Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants L-carnitine, 5% Dextrose - Prematurity, Neurodevelopmental Disorder | Phase 2 / Phase 3 | Completed | Montefiore Medical Center | 144 | 2013-01-01 | 2023-03-08 |
| The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure Levocarnitine Injection, Levocarnitine placebo - Heart Failure, | Phase 2 / Phase 3 | Completed | Lee's Pharmaceutical Limited | 268 | 2011-01-01 | 2012-04-27 |
Showing 20 of 29. Sign in to see all of them.
Fatigue (3) · HIV Infections (2) · Heart Failure (2) · Infertility, Male (2) · Systemic carnitine deficiency (2) · Acne Vulgaris (1) · Acute Kidney Injury (1) · Anemia (1) · Arthritis, Rheumatoid (1) · Atrial Fibrillation (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Cytomegalovirus Infections (1) · Depression (1) · Dyslipidemias (1)
Tanta University (2) · Ain Shams University (1) · All India Institute of Medical Sciences (1) · Asan Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Attikon Hospital (1) · Bahria University (1) · Biolab Sanus Farmaceutica (1) · Centre Hospitalier Universitaire de Nīmes (1) · Children's Oncology Group (1) · ECOG-ACRIN Cancer Research Group (1) · Gdansk University of Physical Education and Sport (1) · Hospital de Clínicas Dr. Manuel Quintela (1) · Kaplan Medical Center (1) · Kochi University (1)
United States (6) · Egypt (4) · France (3) · Canada (2) · Iran (2) · Brazil (1) · China (1) · Germany (1) · Greece (1) · India (1) · Israel (1) · Japan (1) · Mexico (1) · Pakistan (1) · Poland (1)
Acary Souza Bulle Oliveira, MD, PhD (1) · Alaleh Gheisari (1) · Aldo Sgaravatti, MD (1) · Aurelio Cruz Valdez, PhD (1) · Azadeh Eshraghi, Clinical Pharmacist (1) · Azim Hedayatpour, Professor, PhD (1) · Benjamin JW Chow, MD, FRCPC (1) · Brosgart C (1) · Eisa Mohammed Hegazy (1) · Etan Orgel (1) · Fisher E (1) · George Wells, M.Sc., PhD (1) · Golnaz Vaseghi, Ph.D pharmacology (1) · Gulati Sheffali, MD (1)
PMID 10190267, PMID 10650325, PMID 10859281, PMID 10919968, PMID 11277825, PMID 11326085, PMID 11529691, PMID 11729302, PMID 11834528, PMID 11895451, PMID 11975885, PMID 12213433, PMID 12417828, PMID 12421890, PMID 12430089, PMID 12485966, PMID 12686036, PMID 12730697, PMID 12829554, PMID 12867219, PMID 12908852, PMID 12972104, PMID 14607021, PMID 14666956, PMID 15007110, PMID 15331429, PMID 15478042, PMID 15553600, PMID 15591005, PMID 15755765, PMID 15849374, PMID 15855667, PMID 16003294, PMID 16034009, PMID 16377285, PMID 16384561, PMID 16461820, PMID 16554528, PMID 16832163, PMID 16891287, PMID 16903986, PMID 16907655, PMID 17039901, PMID 17047160, PMID 17201631, PMID 17559928, PMID 17569881, PMID 17641743, PMID 17910522, PMID 18246928
2009 (1), U10CA023318 (1), U24CA196173 (1), UG1CA189955 (1)